Adaptimmune Welcome to Adaptimmune Ltd - Adaptimmune

Founded in July 2008, Adaptimmune is focused on the use of T cell therapy to treat cancer and infectious disease. It aims to utilise the bodys own machinery the T cell to target and destroy cancerous or infected cells by using engineered, increased affinity T cell receptor proteins TCRs as a means of strengthening natural patient T cell responses.

OVERVIEW

The web page adaptimmune.com presently has a traffic classification of zero (the smaller the superior). We have traversed four pages inside the website adaptimmune.com and found thirteen websites referencing adaptimmune.com. I observed two contacts and directions for adaptimmune.com to help you connect with them. The web page adaptimmune.com has been online for eight hundred and fifty-six weeks, twenty-six days, fifteen hours, and twenty-two minutes.
Pages Parsed
4
Links to this site
13
Contacts
2
Addresses
2
Online Since
Apr 2008

ADAPTIMMUNE.COM TRAFFIC

The web page adaptimmune.com is seeing fluctuating amounts of traffic throughout the the year.
Traffic for adaptimmune.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for adaptimmune.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for adaptimmune.com

Date Range

All time
This Year
Last Year
Last Month

ADAPTIMMUNE.COM HISTORY

The web page adaptimmune.com was first recorded on April 24, 2008. This web site was changed on April 18, 2014. This site will go back on the market on April 24, 2015. As of today, it is eight hundred and fifty-six weeks, twenty-six days, fifteen hours, and twenty-two minutes young.
REGISTERED
April
2008
UPDATED
April
2014
EXPIRED
April
2015

BUSINESS LENGTH OF LIFE

16
YEARS
4
MONTHS
26
DAYS

LINKS TO WEBSITE

Homepage Foresite Capital

We provide catalytic capital to transformative healthcare companies at all stages. Democratizing access to high quality genetic information. Reversing Tumors Associated With Immunosuppression. Revolutionizing Type 2 Diabetes and Obesity Treatment. Protecting People From Food Allergens. Addressing Glaucoma With Triple-Action Eyedrops. Changing the Definition of Sequencing.

MaSTherCell

Please rotate your device to portrait mode. Environmental Monitoring and Logistic Expert. Production Shared Service Equipment and Facilities Expert. Your Ultimate Cell Therapy Manufacturing Partner. Bringing Highly Potent Cell Therapy Products To The Market. In A Fast And Cost Efficient Way. Expertise and Focus On Cell Therapy. We Help Bring Potent .

Multiple Myeloma News Events Tips Help -The Myeloma-Crowd

What is Multiple Myeloma? Signs and Symptoms of Multiple Myeloma Cancer. How Is Multiple Myeloma Diagnosed? Types of Multiple Myeloma. Past Myeloma Crowd Round Tables. Find a Myeloma Clinical Trial on SparkCures. Myeloma Crowd Wish Charm on ericasara Designs.

OBN Supporting the UKs Innovative Life Sciences Companies Supporting the UKs Innovative Life Sciences Companies

Our 400-plus Member companies are located across the Golden Triangle and beyond to Manchester, Nottingham, the Midlands, South Coast and Scotland, benefiting from our. OBN ist ein gemeinnütziger Verband in Großbritannien, der eine führende Stellung bei der Unterstützung und Vernetzung.

Immuno-Oncology News - The Webs Daily Resource for Immuno-Oncology News

Cancer Immunotherapy Based on Engineered Immune Cells as a Promising Approach Against Myeloma. Potential New Immunotherapy For Melanoma. Enhancing Anti-Tumoral Immunity by Inhibiting Specific Enzyme. Immune Checkpoint Protein Blockade And Low Dose Entire Body Irradiation Identified As Myeloma Immunotherapy. Potential New Immunotherapy For Melanoma.

EU Advanced Therapies Investor Day Leading Advanced Therapies Investor Day

See the list of senior executives, top academics and cell and gene therapy company representatives who spoke at the 2016 meeting. 200 attendees including active investors and analysts. London NW1, United Kingdom.

WHAT DOES ADAPTIMMUNE.COM LOOK LIKE?

Desktop Screenshot of adaptimmune.com Mobile Screenshot of adaptimmune.com Tablet Screenshot of adaptimmune.com

CONTACTS

Adaptimmune Ltd

91 Park Drive Milton Park

Abingdon, Oxfordshire, OX14 4RY

GB

Zen Internet

DNS Master

Sandbrook Park Sandbrook Way

Rochdale, Lancashire, OL11 1RY

GB

ADAPTIMMUNE.COM SERVER

I diagnosed that the main root page on adaptimmune.com took one thousand seven hundred and twenty-two milliseconds to stream. We could not observe a SSL certificate, so we consider this site not secure.
Load time
1.722 sec
SSL
NOT SECURE
IP
82.71.204.24

NAME SERVERS

ns0.zen.co.uk
ns1.zen.co.uk

SERVER SOFTWARE AND ENCODING

We diagnosed that this domain is implementing the Apache os.

SITE TITLE

Adaptimmune Welcome to Adaptimmune Ltd - Adaptimmune

DESCRIPTION

Founded in July 2008, Adaptimmune is focused on the use of T cell therapy to treat cancer and infectious disease. It aims to utilise the bodys own machinery the T cell to target and destroy cancerous or infected cells by using engineered, increased affinity T cell receptor proteins TCRs as a means of strengthening natural patient T cell responses.

PARSED CONTENT

The web page states the following, "Adaptimmune Announces Appointment of Vice President of Investor Relations." I viewed that the web page stated " Adaptimmune Announces Closing of Initial Public Offering." They also said " Adaptimmune Announces Pricing of Initial Public Offering. American Society of Gene and Cell Therapy ASGCT. 13th to 16th May 2015. International Symposium on Immunotherapy Cancer Vaccine Institute. 15th to 16th May 2015."

ANALYZE SUBSEQUENT WEB SITES

Adapt, Inc.

Adapt is a Florida based corporation founded in 1998 that owns and operates websites and serves as a concept incubator. It operates a number of content sites and e-commerce sites, and is a Gold Level Seller on Amazon. The company prides itself on exemplary customer service, with near perfect ratings from third party customer review sites.

A QUICK LOOK INTO FRIEDRICH NIETZSCHE BY Richard j.Kosciejew

The consequence is separation, isolation, suffering, and spiritual death-in a word, the lovelessness of the abyss. 8217; This perspective on the.

Adapting Sideways

The dwindling market for original screenplays in Hollywood has left aspiring screenwriters looking to the literary market to find an audience for their stories. But the process of adapting from a screenplay into a novel presents unique storytelling issues that have yet to be formally addressed. Sunday, May 23, 2010. I had adopted a film-editor mentality to adapt my screenplay and construct a compelling story structure for the novel.